eMedicine Specialties > Cardiology > Peripheral Vascular Disease

Aortitis: Multimedia

Author: Masato Okada, MD, FACP, FACR, FAAAAI, Consulting Staff, Section of Allergy and Rheumatology, Department of Medicine, St Luke's International Hospital, Tokyo
Coauthor(s): Justin D Pearlman, MD, PhD, ME, MA, Director of Dartmouth Advanced Imaging Center, Professor of Medicine, Professor of Radiology, Adjunct Professor, Thayer Bioengineering and Computer Science, Dartmouth-Hitchcock Medical Center
Contributor Information and Disclosures

Updated: Mar 25, 2008

Multimedia

Leukocyte infiltration of the vasovasorum of the ...Media file 1: Leukocyte infiltration of the vasovasorum of the aorta accompanies arteritis obliterans and ischemic necrosis of the media in a case of syphilitic aortitis.
Leukocyte infiltration of the vasovasorum of the ...

Leukocyte infiltration of the vasovasorum of the aorta accompanies arteritis obliterans and ischemic necrosis of the media in a case of syphilitic aortitis.

Granulomatous arteritis with thrombosis of a cere...Media file 2: Granulomatous arteritis with thrombosis of a cerebral vessel may present as a neurological defect with no obvious vascular disease by history or physical.
Granulomatous arteritis with thrombosis of a cere...

Granulomatous arteritis with thrombosis of a cerebral vessel may present as a neurological defect with no obvious vascular disease by history or physical.

Diffuse stenosis from the aortic arch to the abdo...Media file 3: Diffuse stenosis from the aortic arch to the abdominal aorta. The left common carotid artery are also stenotic and the left subclavian artery is not visualized.
Diffuse stenosis from the aortic arch to the abdo...

Diffuse stenosis from the aortic arch to the abdominal aorta. The left common carotid artery are also stenotic and the left subclavian artery is not visualized.

Dilatation of the bilateral vertebral arteries. O...Media file 4: Dilatation of the bilateral vertebral arteries. Occlusion of the right internal carotid artery. Severe stenosis of the left internal carotid artery. Moderate stenosis of the left external carotid artery at the bifurcation with dilated collateral circulation.
Dilatation of the bilateral vertebral arteries. O...

Dilatation of the bilateral vertebral arteries. Occlusion of the right internal carotid artery. Severe stenosis of the left internal carotid artery. Moderate stenosis of the left external carotid artery at the bifurcation with dilated collateral circulation.

Moderate stenosis of the external iliac artery at...Media file 5: Moderate stenosis of the external iliac artery at the bifurcation and occlusion of the right femoral artery.
Moderate stenosis of the external iliac artery at...

Moderate stenosis of the external iliac artery at the bifurcation and occlusion of the right femoral artery.

Frequency of vascular involvement (adapted from c...Media file 6: Frequency of vascular involvement (adapted from combined reports by Maksimowicz-McKinnon et al and Kerr).
Frequency of vascular involvement (adapted from c...

Frequency of vascular involvement (adapted from combined reports by Maksimowicz-McKinnon et al and Kerr).

Presence of associated morbidity in Takayasu arte...Media file 7: Presence of associated morbidity in Takayasu arteritis in the United States (adapted from combined reports by Maksimowicz-McKinnon et al and Kerr).
Presence of associated morbidity in Takayasu arte...

Presence of associated morbidity in Takayasu arteritis in the United States (adapted from combined reports by Maksimowicz-McKinnon et al and Kerr).

More on Aortitis

Overview: Aortitis
Differential Diagnoses & Workup: Aortitis
Treatment & Medication: Aortitis
Follow-up: Aortitis
Multimedia: Aortitis
References

References

  1. Rojo-Leyva F, Ratliff NB, Cosgrove DM. Study of 52 patients with idiopathic aortitis from a cohort of 1,204 surgical cases. Arthritis Rheum. Apr 2000;43(4):901-7. [Medline].

  2. Vanoli M, Daina E, Salvarani C, Sabbadini MG, Rossi C, Bacchiani G. Takayasu's arteritis: A study of 104 Italian patients. Arthritis Rheum. Feb 15 2005;53(1):100-7. [Medline].

  3. Hall S, Barr W, Lie JT. Takayasu arteritis. A study of 32 North American patients. Medicine (Baltimore). Mar 1985;64(2):89-99. [Medline].

  4. Eichhorn J, Sima D, Thiele B. Anti-endothelial cell antibodies in Takayasu arteritis. Circulation. Nov 15 1996;94(10):2396-401. [Medline].

  5. Chauhan SK, Tripathy NK, Nityanand S. Antigenic targets and pathogenicity of anti-aortic endothelial cell antibodies in Takayasu arteritis. Arthritis Rheum. Jul 2006;54(7):2326-33. [Medline].

  6. Matsuyama A, Sakai N, Ishigami M. Matrix metalloproteinases as novel disease markers in Takayasu arteritis. Circulation. Sep 23 2003;108(12):1469-73. [Medline].

  7. Yamada I, Nakagawa T, Himeno Y. Takayasu arteritis: evaluation of the thoracic aorta with CT angiography. Radiology. Oct 1998;209(1):103-9. [Medline].

  8. Andrews J, Al-Nahhas A, Pennell DJ. Non-invasive imaging in the diagnosis and management of Takayasu's arteritis. Ann Rheum Dis. Aug 2004;63(8):995-1000. [Medline].

  9. Meller J, Strutz F, Siefker U. Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging. May 2003;30(5):730-6. [Medline].

  10. Hoffman GS, Leavitt RY, Kerr GS. Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Arthritis Rheum. Apr 1994;37(4):578-82. [Medline].

  11. Daina E, Schieppati A, Remuzzi G. Mycophenolate mofetil for the treatment of Takayasu arteritis: report of three cases. Ann Intern Med. Mar 2 1999;130(5):422-6. [Medline].

  12. Hoffman GS, Merkel PA, Brasington RD. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum. Jul 2004;50(7):2296-304. [Medline].

  13. Nuenninghoff DM, Hunder GG, Christianson TJ, McClelland RL, Matteson EL. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum. Dec 2003;48(12):3522-31. [Medline].

  14. Matsuyama A, Sakai N, Ishigami M, Hiraoka H, Yamashita S. Minocycline for the treatment of Takayasu arteritis. Ann Intern Med. Sep 6 2005;143(5):394-5. [Medline].

  15. Liang P, Tan-Ong M, Hoffman GS. Takayasu's arteritis: vascular interventions and outcomes. J Rheumatol. Jan 2004;31(1):102-6. [Medline].

  16. Arend WP, Michel BA, Bloch DA. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. Aug 1990;33(8):1129-34. [Medline].

  17. Bassa A, Desai DK, Moodley J. Takayasu's disease and pregnancy. Three case studies and a review of the literature. S Afr Med J. Feb 1995;85(2):107-12. [Medline].

  18. Cid MC, Font C, Coll-Vinent B. Large vessel vasculitides. Curr Opin Rheumatol. Jan 1998;10(1):18-28. [Medline].

  19. Dabague J, Reyes PA. Takayasu arteritis in Mexico: a 38-year clinical perspective through literature review. Int J Cardiol. Aug 1996;54 Suppl:S103-9. [Medline].

  20. Di Giacomo V. A case of Takayasu's disease occurred over two hundred years ago. Angiology. Nov 1984;35(11):750-4. [Medline].

  21. Fields CE, Bower TC, Cooper LT, Hoskin T, Noel AA, Panneton JM. Takayasu's arteritis: operative results and influence of disease activity. J Vasc Surg. Jan 2006;43(1):64-71. [Medline].

  22. Grasland A, Pouchot J, Hachulla E, Blétry O, Papo T, Vinceneux P. Typical and atypical Cogan's syndrome: 32 cases and review of the literature. Rheumatology (Oxford). Aug 2004;43(8):1007-15. [Medline].

  23. Hata A, Noda M, Moriwaki R. Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol. Aug 1996;54 Suppl:S155-63. [Medline].

  24. Ishikawa K. Natural history and classification of occlusive thromboaortopathy (Takayasu's disease). Circulation. Jan 1978;57(1):27-35. [Medline].

  25. Ishikawa K. Survival and morbidity after diagnosis of occlusive thromboaortopathy (Takayasu's disease). Am J Cardiol. May 1981;47(5):1026-32. [Medline].

  26. Ishikawa K, Maetani S. Long-term outcome for 120 Japanese patients with Takayasu's disease. Clinical and statistical analyses of related prognostic factors. Circulation. Oct 1994;90(4):1855-60. [Medline].

  27. Kerr GS. Takayasu's arteritis. Rheum Dis Clin North Am. Nov 1995;21(4):1041-58. [Medline].

  28. Kerr GS, Hallahan CW, Giordano J. Takayasu arteritis. Ann Intern Med. Jun 1 1994;120(11):919-29. [Medline].

  29. Lupi-Herrera E, Sanchez-Torres G, Marcushamer J. Takayasu's arteritis. Clinical study of 107 cases. Am Heart J. Jan 1977;93(1):94-103. [Medline].

  30. Maksimowicz-McKinnon K, Clark TM, Hoffman GS. Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum. Mar 2007;56(3):1000-9. [Medline].

  31. Maksimowicz-McKinnon K, Hoffman GS. Takayasu arteritis: what is the long-term prognosis?. Rheum Dis Clin North Am. Nov 2007;33(4):777-86, vi. [Medline].

  32. Matsunaga N, Hayashi K, Sakamoto I. Takayasu arteritis: MR manifestations and diagnosis of acute and chronic phase. J Magn Reson Imaging. Mar-Apr 1998;8(2):406-14. [Medline].

  33. Michel BA, Arend WP, Hunder GG. Clinical differentiation between giant cell (temporal) arteritis and Takayasu's arteritis. J Rheumatol. Jan 1996;23(1):106-11. [Medline].

  34. Misra R, Aggarwal A, Chag M. Raised anticardiolipin antibodies in Takayasu's arteritis. Lancet. Jun 25 1994;343(8913):1644-5. [Medline].

  35. Nakabayashi K, Kurata N, Nangi N. Pulmonary artery involvement as first manifestation in three cases of Takayasu arteritis. Int J Cardiol. Aug 1996;54 Suppl:S177-83. [Medline].

  36. Nesher G, Berkun Y, Mates M, Baras M, Rubinow A, Sonnenblick M. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum. Apr 2004;50(4):1332-7. [Medline].

  37. Numano F, Kobayashi Y. Takayasu arteritis--beyond pulselessness. Intern Med. Mar 1999;38(3):226-32. [Medline].

  38. Numano F, Okawara M, Inomata H. Takayasu's arteritis. Lancet. Sep 16 2000;356(9234):1023-5. [Medline].

  39. Rao SA, Mandalam KR, Rao VR. Takayasu arteritis: initial and long-term follow-up in 16 patients after percutaneous transluminal angioplasty of the descending thoracic and abdominal aorta. Radiology. Oct 1993;189(1):173-9. [Medline].

  40. Rodriguez-Pla A, de Miguel G, Lopez-Contreras J. Bilateral blindness in Takayasu's disease. Scand J Rheumatol. 1996;25(6):394-5. [Medline].

  41. Seko Y. Takayasu arteritis: insights into immunopathology. Jpn Heart J. Jan 2000;41(1):15-26. [Medline].

  42. Sharma BK, Jain S, Sagar S. Systemic manifestations of Takayasu arteritis: the expanding spectrum. Int J Cardiol. Aug 1996;54 Suppl:S149-54. [Medline].

  43. Subramanyan R, Joy J, Balakrishnan KG. Natural history of aortoarteritis (Takayasu's disease). Circulation. Sep 1989;80(3):429-37. [Medline].

  44. Sun Y, Yip PK, Jeng JS. Ultrasonographic study and long-term follow-up of Takayasu's arteritis. Stroke. Dec 1996;27(12):2178-82. [Medline].

  45. Yasuda K. Surgical treatment of Takayasu's Arteritis. Intern Med. Nov 1998;37(11):903-4. [Medline].

  46. Zhuang H, Yu JQ, Alavi A. Applications of fluorodeoxyglucose-PET imaging in the detection of infection and inflammation and other benign disorders. Radiol Clin North Am. Jan 2005;43(1):121-34. [Medline].

Further Reading

Keywords

aortitis, Takayasu's arteritis, Takayasu arteritis, pulseless disease, pulselessness, giant cell arteritis, polyarteritis nodosa, Kawasaki disease, large vessel arteritis, vasculitis

Contributor Information and Disclosures

Author

Masato Okada, MD, FACP, FACR, FAAAAI, Consulting Staff, Section of Allergy and Rheumatology, Department of Medicine, St Luke's International Hospital, Tokyo
Masato Okada, MD, FACP, FACR, FAAAAI is a member of the following medical societies: American Academy of Allergy Asthma and Immunology, American College of Physicians, and American College of Rheumatology
Disclosure: Nothing to disclose.

Coauthor(s)

Justin D Pearlman, MD, PhD, ME, MA, Director of Dartmouth Advanced Imaging Center, Professor of Medicine, Professor of Radiology, Adjunct Professor, Thayer Bioengineering and Computer Science, Dartmouth-Hitchcock Medical Center
Justin D Pearlman, MD, PhD, ME, MA is a member of the following medical societies: American College of Cardiology, American College of Physicians, American Federation for Medical Research, International Society for Magnetic Resonance in Medicine, and Radiological Society of North America
Disclosure: Nothing to disclose.

Medical Editor

Russell F Kelly, MD, Program Director, Assistant Professor, Department of Internal Medicine, Division of Cardiology, Cook County Hospital, Rush Medical College
Russell F Kelly, MD is a member of the following medical societies: American College of Cardiology
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Ronald J Oudiz, MD, Director of Pulmonary Hypertension, Associate Professor, Department of Medicine, Division of Cardiology, Harbor-UCLA Medical Center, David Geffen School of Medicine at UCLA
Ronald J Oudiz, MD is a member of the following medical societies: American College of Cardiology, American College of Physicians, and American Heart Association
Disclosure: Actelion Grant/research funds Clinical Trials + honoraria; Encysive Grant/research funds Clinical Trials + honoraria; Gilead Grant/research funds Clinical Trials + honoraria; Pfizer Grant/research funds Clinical Trials + honoraria; United Therapeutics Grant/research funds Clinical Trials + honoraria

CME Editor

Amer Suleman, MD, Consultant in Electrophysiology and Cardiovascular Medicine, Department of Internal Medicine, Division of Cardiology, Medical City Dallas Hospital
Amer Suleman, MD is a member of the following medical societies: American College of Physicians, American Heart Association, American Institute of Stress, American Society of Hypertension, Federation of American Societies for Experimental Biology, Royal Society of Medicine, and Society of Cardiac Angiography and Interventions
Disclosure: Nothing to disclose.

Chief Editor

George A Stouffer III, MD, Henry A Foscue Distinguished Professor of Medicine and Cardiology, Director of Interventional Cardiology, Cardiac Catheterization Laboratory, Chief of Clinical Cardiology, Division of Cardiology, University of North Carolina Medical Center
George A Stouffer III, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Cardiology, American College of Physicians, American Heart Association, Phi Beta Kappa, and Society for Cardiac Angiography and Interventions
Disclosure: Nothing to disclose.

RELATED MEDSCAPE ARTICLES
Articles
 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.